Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Younger women face breast cancer risk in Africa, SGU warns

    October 22, 2026

    Sheikh Khaled begins official visit to Greece in Athens

    October 22, 2026

    Korean exports double to $61.6 billion on chip shipments

    October 22, 2026
    Senegal GazetteSenegal Gazette
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Senegal GazetteSenegal Gazette
    Home » BioMed X Launches a New Call for Application in Autoimmune Disease Research
    ACCESS Newswire

    BioMed X Launches a New Call for Application in Autoimmune Disease Research

    November 7, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.

    HEIDELBERG, GERMANY / ACCESSWIRE / November 7, 2023 / BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology. This call aims to assemble a new research team to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune disease.

    Current therapeutic strategies for autoimmune diseases primarily focus on broadly suppressing the immune response, with significant side effects. More importantly, none of these treatments address one of the root causes of the disease, the autoreactive plasma cells that produce antibodies targeting self-antigens. By exploring the deep biology of human autoreactive plasma cells to identify biomarkers that distinguish them from their physiological counterparts, this project aims to identify new therapeutic strategies to selectively eliminate these cells in patients suffering from autoimmune diseases.

    “Immunology – including autoimmunity – is one of our R&D focus areas at our BioMed X Institutes in Heidelberg, New Haven, and our XSeed Labs in Ridgefield. Currently, we are hosting five immunology research teams at different stages of development. We are excited to extend our immunology research capabilities with this new project in the field of autoreactive plasma cells,” explains Christian Tidona, Founder and Managing Director of the BioMed X Institute.

    This new research group will be located at the BioMed X Institute in Heidelberg, Germany. Each BioMed X project is a collaboration with a leading pharmaceutical company. To learn more about this project and how to apply, visit the BioMed X Career Space at https://career.bio.mx/call/2023-BMX-C02. The deadline for applying is January 7, 2023.

    About BioMed X

    BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world’s brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds – academia and industry – and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.

    Contact Information:

    Flavia-Bianca Cristian
    Recruiting & Communications Manager
    fbc@bio.mx
    +49 6221 426 11 706

    Related Images

    SOURCE: BioMed X Institute

    View source version on accesswire.com:
    https://www.accesswire.com/800139/biomed-x-launches-a-new-call-for-application-in-autoimmune-disease-research

    Related Posts

    Chervon Names Terry Lucero Director of National Accounts – Industrial

    October 19, 2026

    Digi Power X Announces $200 Million Debt Financing Commitment to Support Completion of Alabama AI Data Center and Provides Expansion Update

    October 13, 2026

    Chervon Names Randall Durkan Vice President of Supply Chain – North America

    October 12, 2026

    Nevada Court Lifts Restriction, Clearing EESystem to Share Recording of November 2024 Meeting

    October 7, 2026

    U.S. Polo Assn. Celebrates an Outstanding 2026 European Polo Season

    October 6, 2026

    Chervon Appoints Neil Harrison to the Position of VP Sales, Marketing and MD for Chervon Canada

    October 5, 2026
    News Bulletin

    Younger women face breast cancer risk in Africa, SGU warns

    October 22, 2026

    – More than one in five women diagnosed with breast cancer in five sub-Saharan African countries were younger than 40, according to a study highlighted by St. George’s University. The figure of 21.9% has prompted the university to call for

    Sheikh Khaled begins official visit to Greece in Athens

    October 22, 2026

    – Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi, has begun an official visit to Greece after arriving in Athens. Greek Foreign Minister George Gerapetritis welcomed him at Athens International Airport. Sheikh Khaled is visiting

    Korean exports double to $61.6 billion on chip shipments

    October 22, 2026

    – South Korea’s exports more than doubled from a year earlier in the first 20 days of October, reaching $61.6 billion on record semiconductor shipments. The Korea Customs Service released the data on Wednesday. Average daily exports, measured by working

    Türkiye aims to rank sixth in global tourism revenue

    October 21, 2026

    – Türkiye has set its sights on becoming the sixth-highest-earning tourism country in the world, according to its 2027 central government budget draft. Anadolu Agency reported that the draft allocates $244.5 million to tourism, compared with $188.4 million this year.

    © 2026 Senegal Gazette | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.